All In Biotech

Drug Trial Radar · NCT00608023

TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy

A Multicenter, Double-blind, Randomized, Placebo-controlled Extension Study Assessing the Efficacy and Long-term Safety of a 2 mg Dose of TH9507, a GHRH Analog, in HIV Subjects With Excess Abdominal Fat Accumulation

Last checked: Nov 20, 2026Latest source record: Sep 30, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 263 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

263

Actual

Start

Aug 2007

Primary completion

Oct 2008

Study completion Oct 2008

Sponsor

Lead sponsor
TheratechnologiesIndustry
Sponsor type
Industry
First posted
Feb 6, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Assessing the Efficacy and Long-Term Safety of a 2 mg dose of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Subjects with Excess Abdominal Fat Accumulation

Conditions

  • Lipodystrophy
  • HIV Infections

Interventions

  • TesamorelinDrug

  • Placebo for TesamorelinDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Changes From Baseline in Fasting Blood Glucose at Week 52Time frame: Baseline and Week 52
  2. Changes From Baseline in 2 h Oral Glucose Tolerance Test (OGTT) at Week 52Time frame: Baseline and Week 52

Locations

47 sites in 6 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Body Positive Inc.

    Phoenix, Arizona

  • Somero, Michael

    Indio, California

  • UCLA School of Medicine

    Los Angeles, California

  • Office of Dr. Michael Somero

    Palm Springs, California

  • University of California

    San Francisco, California

  • Kaiser Permanente

    San Francisco, California

  • UCSF/VA Medical Center

    San Francisco, California

  • AIDS Research Alliance

    West Hollywood, California

  • Denver Public Health Department

    Denver, Colorado

  • Office of Dr. Gary Richmond

    Fort Lauderdale, Florida

  • Hendry/Glades County Health Departments

    LaBelle, Florida

  • Infectious Disease Research Institute Inc.

    Tampa, Florida

  • AIDS Research Consortium Atlanta (ARCA)

    Atlanta, Georgia

  • Northern Healthcare

    Chicago, Illinois

  • Northstar Medical

    Chicago, Illinois

  • Indiana University Department of Medicine

    Indianapolis, Indiana

  • Tufts University School of Medicine

    Boston, Massachusetts

  • Massachusetts General Hospital

    Boston, Massachusetts

  • The Research Institute

    Springfield, Massachusetts

  • ID Associates

    Hillsborough, New Jersey

  • AIDS Community Research Initiative of America

    New York, New York

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina

  • University Hospitals of Cleveland

    Cleveland, Ohio

  • Central Texas Clinical Research

    Austin, Texas

  • University of Texas Southwestern Medical Center at Dallas

    Dallas, Texas

  • Swedish Medical Center

    Seattle, Washington

  • C. H. U. Sart-Tilman

    Liège, Belgium

  • St-Paul's Hospital

    Vancouver, British Columbia, Canada

  • McMaster University Health Sciences Centre

    Hamilton, Ontario, Canada

  • Sunnybrook Health Sciences Centre

    Toronto, Ontario, Canada

  • Toronto General Hospital

    Toronto, Ontario, Canada

  • Centre Hospitalier Universitaire de Santé de l'Estrie

    Fleurimont, Quebec, Canada

  • Montreal General Hospital

    Montreal, Quebec, Canada

  • Groupe de Recherche en Rhumatologie et maladies osseuses

    Ste-Foy, Quebec, Canada

  • Hôpital Hotel Dieu Lyon

    Lyon, France

  • Hotel Dieu

    Nantes, France

  • Hopital Europeen Georges Pompidou

    Paris, France

  • Hopital Necker

    Paris, France

  • Hosp. Ramon y Cajal

    Madrid, Spain

Showing 40 of 47 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.